News

News

BNC#9 | Fired for pitching an 'unlistable' idea, Afrimat CEO v Heerden built a R10bn company anyway
BNC

BNC#9 | Fired for pitching an 'unlistable' idea, Afrimat CEO v Heerden built a R10bn company anyway

By
Editor BizNews
1 min read
Afrimat's Andries van Heerden on being fired for his big idea, turning around Lafarge, and why deindustrialisation is now his biggest threat.
The BHP Group Ltd. logo
miningweb

BHP's best numbers in years comes with a $2.3 billion asterisk

By
Alec Hogg
5 min read
BHP’s record profits mask rising costs, copper dependence and a strategic dilemma
A statue of Sherlock Holmes in London
Rational Perspective

How smart was Sherlock Holmes's arch enemy Moriarty?

By
Daily Friend
6 min read
IQ, crime and the chilling odds of getting away with murder
A general view of Absa Bank at Absa Towers West in Johannesburg, South Africa.
SA Investing

Absa's numbers look good until you check who's actually pulling the cart

By
Alec Hogg
4 min read
Absa’s South African engine is carrying the group as its African growth story falters
BNC#9 | Sasol CEO Simon Baloyi: Turning around an SA giant through Trump, tariffs and turmoil
BNC

BNC#9 | Sasol CEO Simon Baloyi: Turning around an SA giant through Trump, tariffs and turmoil

By
Editor BizNews
1 min read
Sasol CEO Simon Baloyi on the turnaround from a R70 a share loss, US tariffs on chemical exports, and why coal still matters to South Africa.
Big Pharma's latest obsession - The brain may be about to have its Ozempic moment
Health

Big Pharma's latest obsession - The brain may be about to have its Ozempic moment

By
The Economist
6 min read
Pharma’s newest obsession involves mimicking the system that keeps people awake
BizNews
www.biznews.com